00:02
Let's talk a little bit more
about diabetic polyneuropathy
which is particularly common,
and one I would like you to
have a good understanding of.
00:09
This presents most commonly as a distal
symmetric sensorimotor polyneuropathy.
00:14
So that's how
patients describe it.
00:15
And that's what we're evaluating on
both our history and our physical exam.
00:19
Sensory manifestations
are more common than motor
and this presents is a
dying back phenomenon
with a stocking glove distribution
of signs and symptoms.
00:29
It begins distally and progresses
more proximally with time.
00:34
This is primarily due
to axonal degeneration,
but there are varying
degrees of demyelination.
00:40
And that is important,
we think about demyelination
and demyelinating features
on the nerve conduction
and EMG as suggestive of
an inflammatory process.
00:48
But diabetes is one of those
conditions where we see
prominent axonal findings on
the nerve conduction study,
some mild demyelinating
features and that should not
get us off track with working up or
evaluating an immune-mediated disorder
and evaluating and
treating diabetes.
01:05
Here we may see effects on
peripheral primarily sensory
as well as autonomic nerves.
01:11
And so that involvement
of autonomic nerves
presenting with
orthostasis or constipation
can also signal a potential
diagnosis of diabetes.
01:19
The distal portions of sensory and
autonomic nerves are unmyelinated
and can be affected by
this underlying process.
01:27
Lack of myelin creates susceptibility
to damage in these patients.
01:32
Now let's talk about
alcohol-induced polyneuropathy.
01:35
This is one of the three most common
causes of neuropathy in the United States.
01:39
Occurs in 40% of patients
who are chronic alcoholics
primarily axonal in nature, a lot of
these toxic metabolic polyneuropathies
are axonal and alcoholism
is a good example of that.
01:51
Sensory symptoms predominate,
motor weakness can occur.
01:55
This begins with symptoms
in the lower extremity,
upper extremity involvement
is often seen later
in the course of the disease
and sometimes an ataxia
or problems with cerebellar function
can co-occur with this condition.
02:08
Autonomic neuropathy
is often present
and may lead to orthostasis
or other autonomic symptoms.
02:16
Contributing factors include direct
or indirect toxic effects of alcohol.
02:20
Alcohol has both direct effects
on the health of the nerves,
as well as indirect effects
through nutritional deficiency.
02:27
Thiamine deficiency is not
uncommon in chronic alcoholics
and should be evaluated
and treated in patients
with a concerning clinical
presentation or history.
02:37
Inability to metabolize thiamine
in the presence of alcohol
is also a consideration in these patients
and should be treated and managed.
02:45
How do we work up a patient with a
new chronic onset polyneuropathy?
What's the work up for a
toxic metabolic neuropathy?
Well, in general, I like to think
about evaluating the most common,
the most treatable and then some
rare causes of polyneuropathy.
03:02
And you can see here a breakdown
in the diagnostic work up
recommended for patients presenting
with these neuropathic complaints.
03:09
First of all,
we consider laboratory testing.
03:13
Blood urea nitrogen and creatine
and are used to evaluate for uremia.
03:17
A fasting glucose,
random glucose or A1c
can be a good
screen for diabetes.
03:23
But in those were testing as normal,
oral glucose tolerance testing is required
to fully evaluate for
underlying diabetic neuropathy
given the high prevalence and
frequency of diabetic neuropathy.
03:36
Thyroid testing is
important as well as looking
for vitamin B12 deficiency
and folate deficiency.
03:43
RPR testing for
underlying syphilis,
HIV testing can be considered in patients
who with a potential risk factors.
03:51
And in men over the age of 50,
we think about evaluating for an M-spike
with serum protein electrophoresis,
urine protein electrophoresis,
immunofixation,
or a kappa free light chains
or free light chain
testing in the urine.
04:05
That's more common in
men over the age of 50.
04:07
And we think about testing
for a paraproteinemia
or elevation of an
M-spike in those patients.
04:14
In addition, we can consider provocative
testing, electrodiagnostic studies
to evaluate the
underlying neuropathy.
04:22
EMG and a peripheral nerve
conduction velocity study
can be helpful in determining
whether this is axonal
and the majority of toxic metabolic
neuropathies are axonal or demyelinating.
04:33
There are some rare toxic
metabolic conditions
that can present with
demyelinating features.
04:38
Diabetes would be the most
common but there are some other.
04:41
But prominent demyelinating
features should suggest
an inflammatory etiology
and prompt further work up.
04:48
And then lastly, there are some
rare causes of polyneuropathy
and we can test those in
patients where the history
or various findings on physical exam
suggest the possible rare disorder.
04:59
ESR/CRP testing can be a screen
for a systemic autoimmune condition
that may be
affecting the nerves.
05:05
Vitamin B6 toxicity, Vitamin E
deficiency can present with neuropathy.
05:10
Paraneoplastic testing may be needed in
patients where we suspect the cancer.
05:14
Importantly,
paraneoplastic neurologic disorders
can present prior to
the onset of cancer.
05:19
So in patients with neuropathy without
an underlying diagnosis of cancer,
we may need to consider
a paraneoplastic origin.
05:26
Urine porphyrins could
evaluate a porphyric neuropathy
and heavy metal screen for patients
who may have heavy metal toxicity.